Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Limbal Stem Cell Deficiency: early-phase trial registry
1 of 3 indexed Limbal Stem Cell Deficiency trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Limbal Stem Cell Deficiency: 3 US clinical trials tracked, 1 recruiting.
Limbal Stem Cell Deficiency is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Claris Biotherapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition limbal-stem-cell-deficiency
OPEN 1 | RECR 33% | LATE 0 | EARLY 3 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Limbal Stem Cell Deficiency lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Limbal Stem Cell Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Limbal Stem Cell Deficiency is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Claris Biotherapeutics
NCT06452316
Stem Cell Therapy for Limbal Stem Cell Deficiency
University of California, Los Angeles
NCT03957954
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
Massachusetts Eye and Ear Infirmary
NCT02592330
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Limbal Stem Cell Deficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Limbal Stem Cell Deficiency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Limbal Stem Cell Deficiency page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Limbal Stem Cell Deficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Claris Biotherapeutics sponsors the most Limbal Stem Cell Deficiency trials on record, review their full trial history before evaluating a specific study. See Claris Biotherapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Limbal Stem Cell Deficiency condition card totals 3 registered trials; most-linked intervention CALEC Transplant; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.